Launch of New Bioinformatics Solutions and R&D of Novel Bioinformatics Pipeline to Augment Growth of Bioinformatics Market

Bioinformatics Market


 Bioinformatics covers a wide range of scientific areas involving genomics, microbial, and animal and plant sciences. It can be used to design and evaluate sequencing experiments, as well as developing bioinformatics software. Bioinformatics has opened up many new opportunities for researchers due to its focus on information science, specifically computer science. This area of science strives to bridge the gap between the biology and technologies, thus facilitating the meaningful exchange of information.

Market Dynamics

Launch of new bioinformatics solutions is expected to propel growth of the global bioinformatics market. For instance, in January 2021, Illumina launched Illumina Connected Analytics, an integrated bioinformatics solution that provides a comprehensive, private, cloud-based data platform. Moreover, integration of deep learning and bioinformatics is also expected enable in-depth study of glycan molecules for understanding infections, thereby aiding in growth of the market. 

R&D of novel bioinformatics pipeline to identify viruses in host-associated or environmental samples is expected to offer lucrative growth opportunities for players in the global bioinformatics market. High prevalence of cardiovascular diseases is also expected to aid in growth of the market. For instance, according to the American Heart Association's Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of cardiovascular disease in 2016.  

Emergence of Covid-19 has led to increasing adoption of bioinformatics, thereby propelling growth of the global bioinformatics market. For instance, globally, as of 4:58pm CET, 8 February 2021, there have been 105,805,951 confirmed cases of COVID-19, including 2,312,278 deaths, as reported to the World Health Organization. Moreover, increasing funding in bioinformatics is also expected to aid in growth of the market, For instance, in August 2020, Addex Therapeutics, a clinical-stage pharmaceutical company, and the SIB Swiss Institute of Bioinformatics, were awarded a US$ 669 thousand Innosuisse grant to apply computational approaches developed by SIB to identify new therapeutic indications for ADX10061, a potent and selective dopamine D1 receptor antagonist.

Competitive Analysis

Major players operating in the global bioinformatics market include, Active Motif, Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare, Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced BioInformatics GmbH, and Fios Genomics Ltd.

Major players in the global bioinformatics market are focused on R&D to expand their product portfolio. For instance, in June 2020, Intomics announced that the company is a part of the newly funded translate project on personalized diabetes treatment. 

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)